Tags Archive Navigation
icon
-
Media ReleaseNovartis renews WHO medicine donation pledge with aim of ending leprosy
-
Media ReleaseNovartis signs initial agreement to provide manufacturing capacity for Pfizer-BioNTech COVID-19 vaccine
-
Media ReleaseNovartis announces broad range of initiatives to respond to COVID-19 Pandemic; Creates USD 20 million global fund to support impacted communities
-
Media ReleaseNovartis commits to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response
-
Media ReleaseNovartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation
-
Media ReleaseNovartis announces plan to initiate clinical study of Jakavi® in severe COVID-19 patients and establish international compassionate use program
-
Media ReleaseNovartis to sponsor large clinical trial of hydroxychloroquine in hospitalized COVID-19 patients
-
Media ReleaseNovartis Resolves Legacy FCPA Investigations
-
Media ReleaseSandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe
-
Media ReleaseNew collaboration between Novartis and Africa Medical Supplies Platform to facilitate supply of COVID-19 related medicines
-
StoryIn your neighborhood: a community-based approach to health equity in the US
-
StoryDoing the right thing is good business